Aged
Androgen Antagonists
Antineoplastic Agents, Hormonal
Cause of Death
Chemoradiotherapy
Disease Progression
Humans
Male
Middle Aged
Neoplasm Grading
Prostate-Specific Antigen
Prostatic Neoplasms
Radiotherapy Dosage
Survival Analysis
Treatment Outcome